Albemarle is one of the world's largest lithium producers... Show more
Albemarle Corporation is the world's largest lithium producer and a leading specialty chemicals company headquartered in Charlotte, North Carolina. The company operates two primary business segments: Energy Storage, which supplies lithium used in electric-vehicle batteries and grid-scale battery energy storage systems, and Specialties, which includes bromine and other specialty chemicals serving industries such as fire safety, pharmaceuticals, and electronics. Following the March 2026 sale of a 51% stake in its Ketjen refining catalysts business, Albemarle has become a more focused lithium and bromine pure-play. Its competitive strengths include large-scale, relatively low-cost lithium resources across hard-rock and brine assets, a global supply footprint, and a strengthened balance sheet with roughly $3.4 billion in liquidity and a net-debt-to-adjusted-EBITDA ratio near 0.3x. Investors follow ALB closely as a liquid proxy for the lithium and battery-materials cycle.
Over the 30 days ending Nov. 4, 2026, Albemarle shares fell from a closing price of $106.35 to $94.97, a decline of approximately 10.7%. The stock slid steadily through October, touched intraday levels near $89.83 in early November, and then rebounded 5.3% on Nov. 4 after the company reported stronger-than-expected third-quarter results.
The broader three-month trend has been similar. From a close of about $118.84 in early August, the stock is down roughly 20%, having peaked near $143.25 in late August before trending lower. This places Albemarle well below its 2026 highs and near the lower end of its 52-week range, underscoring how much lithium-price sentiment continues to dominate the share price.
The most important factor behind the 30-day decline was renewed weakness in lithium pricing. Lithium carbonate prices slid toward fresh 2026 lows in late October, pressuring the outlook for Albemarle's realized prices and earnings power even as the company reported improving financial results.
Analyst actions amplified the selling pressure. During the period, multiple firms trimmed their targets on ALB, including BMO Capital (to $175 from $200), UBS (to $150), Argus (to $135 from $230), and Citigroup (to $125 from $175). Consensus earnings estimates were also marked down in the weeks leading into the quarterly report, reflecting softer volume and pricing assumptions for the Energy Storage segment.
A more cautious macroeconomic backdrop added to the headwinds. Rising market-implied expectations for further Federal Reserve rate hikes weighed on rate-sensitive, cyclically exposed materials stocks, while sharp weakness across specialty-chemical peers such as FMC dampened sector sentiment. By contrast, the Nov. 4 earnings release provided a positive catalyst, with adjusted EPS of $2.58 beating the FactSet consensus of about $2.53 and a lower capital-expenditure outlook supporting the day's rebound.
The quarterly decline reflects the broader lithium cycle rather than any single event. Lithium prices recovered into mid-2026, helping drive a strong second quarter in which Albemarle's net sales rose 31% and adjusted EBITDA more than doubled. However, management cautioned in early August that Energy Storage sales and EBITDA would decline sequentially in the third quarter on lower volumes and pricing, and lithium prices subsequently rolled over again.
Supply-side disruptions also shaped the quarter. A June 9 fire at the Talison CGP3 processing plant delayed the ramp-up of that facility, contributing to full-year Energy Storage volume guidance of 225,000 to 235,000 kilotons of lithium carbonate equivalent. Combined with cautious analyst revisions and sector rotation out of cyclical materials, these factors pushed the stock from its late-August peak near $143 down to the low-to-mid $90s by early November, a decline of roughly 20% over the period.
Tickeron's Trending AI Robots page is a curated hub where traders and investors can explore AI-driven trading bots active across thousands of tickers. While Tickeron offers hundreds of bots covering a wide range of strategies, only the top-performing and most relevant models are featured in this section, making it easier to filter for quality. The bots vary considerably in strategy, holding timeframe, and performance metrics, so users can compare approaches that suit different risk profiles and trading styles. For those following stocks such as ALB, the page provides a way to see whether automated strategies are currently positioning in the name. Exploring the Trending AI Robots section can help surface data-driven signals and add a systematic perspective to your research.
Looking ahead, investors are likely to focus on management's 2027 commentary and fourth-quarter guidance, particularly assumptions for realized lithium pricing and Energy Storage volumes. The pace of the Talison CGP3 ramp and contributions from the Wodgina operation will be closely tracked against the full-year volume range. Lithium market dynamics remain central, including supply discipline among major producers, inventory levels, and the trajectory of battery energy storage demand, which has become a meaningful offset to softer EV growth. Macroeconomic conditions, interest-rate expectations, and any further analyst estimate revisions will also influence sentiment. Albemarle's low-cost position, cost-reduction progress, and balance-sheet strength provide a measure of resilience, but the stock's near-term direction is likely to remain tied to the lithium price environment.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where ALB declined for three days, in 269 of 323 cases, the price declined further within the following month. The odds of a continued downward trend are 83%.
The Momentum Indicator moved below the 0 level on November 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ALB as a result. In 63 of 81 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 78%.
The Moving Average Convergence Divergence Histogram (MACD) for ALB turned negative on November 17, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In 36 of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at 78%.
The Aroon Indicator for ALB entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +4.51% 3-day Advance, the price is estimated to grow further. Considering data from situations where ALB advanced for three days, in 241 of 305 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
ALB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Price Growth Rating for this company is 65 (best 1 - 100 worst), indicating fairly steady price growth. ALB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 69 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 89 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.457) is normal, around the industry mean (2.284). ALB has a moderately high P/E Ratio (211.170) as compared to the industry average of (-17.137). Projected Growth (PEG Ratio) (0.959) is also within normal values, averaging (1.548). Dividend Yield (0.017) settles around the average of (0.039) among similar stocks. P/S Ratio (2.352) is also within normal values, averaging (48.960).
The Tickeron SMR rating for this company is 90 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ALB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of specialty polymers, chemicals and related products
Industry ChemicalsSpecialty